Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Badreddin Edris

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Oncoimmunology|November 22, 2012
Flipping the script on macrophages in leiomyosarcomaBadreddin Edris, Kipp Weiskopf, Irving L Weissman, et al.
Sarcoma|August 25, 2012
Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcomaBadreddin Edris, Jonathan A Fletcher, Robert B West, et al.
Oncoimmunology|July 30, 2013
Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumorsBadreddin Edris, Stephen Willingham, Kipp Weiskopf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
The macrophage colony-stimulating factor 1 response signature in breast carcinomaAndrew H Beck, Inigo Espinosa, Badreddin Edris, et al.
The Journal of Biological Chemistry|October 17, 2014
A role for versican in the development of leiomyosarcomaPaul A Keire, Steven L Bressler, Joan M Lemire, et al.
The Journal of Experimental Medicine|May 15, 2013
Inactivation of the RB family prevents thymus involution and promotes thymic function by direct control of Foxn1 expressionPhillip M Garfin, Dullei Min, Jerrod L Bryson, et al.
Cancer Epidemiology|February 5, 2022
The epidemiology of desmoid tumors in DenmarkMarie Anneberg, Helene M L Svane, Jon Fryzek, et al.
The American Journal of Pathology|August 23, 2011
CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesisIñigo Espinosa, Badreddin Edris, Cheng-Han Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcomaBadreddin Edris, Kipp Weiskopf, Anne K Volkmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2013
Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growthBadreddin Edris, Stephen B Willingham, Kipp Weiskopf, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Oncoimmunology|November 22, 2012
Flipping the script on macrophages in leiomyosarcomaBadreddin Edris, Kipp Weiskopf, Irving L Weissman, et al.
Sarcoma|August 25, 2012
Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcomaBadreddin Edris, Jonathan A Fletcher, Robert B West, et al.
Oncoimmunology|July 30, 2013
Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumorsBadreddin Edris, Stephen Willingham, Kipp Weiskopf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
The macrophage colony-stimulating factor 1 response signature in breast carcinomaAndrew H Beck, Inigo Espinosa, Badreddin Edris, et al.
The Journal of Biological Chemistry|October 17, 2014
A role for versican in the development of leiomyosarcomaPaul A Keire, Steven L Bressler, Joan M Lemire, et al.
The Journal of Experimental Medicine|May 15, 2013
Inactivation of the RB family prevents thymus involution and promotes thymic function by direct control of Foxn1 expressionPhillip M Garfin, Dullei Min, Jerrod L Bryson, et al.
Cancer Epidemiology|February 5, 2022
The epidemiology of desmoid tumors in DenmarkMarie Anneberg, Helene M L Svane, Jon Fryzek, et al.
The American Journal of Pathology|August 23, 2011
CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesisIñigo Espinosa, Badreddin Edris, Cheng-Han Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcomaBadreddin Edris, Kipp Weiskopf, Anne K Volkmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2013
Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growthBadreddin Edris, Stephen B Willingham, Kipp Weiskopf, et al.
Pageof 2